Buscar en
Enfermedades Infecciosas y Microbiología Clínica (English Edition)
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica (English Edition) Chorioamnionitis and neonatal septicaemia due to Eikenella corrodens
Journal Information
Vol. 35. Issue 4.
Pages 266-267 (April 2017)
Vol. 35. Issue 4.
Pages 266-267 (April 2017)
Scientific letter
DOI: 10.1016/j.eimce.2016.03.001
Full text access
Chorioamnionitis and neonatal septicaemia due to Eikenella corrodens
Corioamnionitis y sepsis neonatal causada por Eikenella corrodens
Itziar Angulo Lópeza,
Corresponding author

Corresponding author.
, Amaia Aguirre Quiñoneroa, Marina Fernández Torresa, Estíbaliz Alegría Echaurib
a Servicio de Microbiología, Hospital Universitario Marqués de Valdecilla-IDIVAL, Santander, Spain
b Servicio de Pediatría, Hospital Universitario Marqués de Valdecilla, Santander, Spain
Article information
Full Text
Download PDF
Figures (1)
Full Text

Eikenella corrodens (E. corrodens) is a slow-growing, Gram-negative, facultative anaerobic coccobacillus commonly found in the flora of the oral cavity, the upper respiratory tract and the digestive tract. It most often causes head, neck and intra-abdominal infections, as well as endocarditis and human bite infections.1 However, there are very few cases of obstetric and gynaecological infections to be found in the literature.

We present a case of chorioamnionitis and neonatal sepsis caused by E. corrodens.

A 25-year-old woman presented with a dichorionic diamniotic twin pregnancy at 24+3 weeks and was admitted for cervical effacement without having gone into labour. The patient had no relevant medical history and the prenatal screening was normal. On the tenth day of admission, and after premature rupture of membranes, the patient went into spontaneous labour, requiring a Caesarian section as one of the twins was lying transverse. Given that chorioamnionitis was suspected, a placenta sample was sent for microbiological culture and histological examination.

The newborn (800g) presented clinical and biochemical signs of infection. The blood count revealed 4000leukocytes/μl, (9% segmented, 72% lymphocytes and 15% monocytes) and 112,000platelets/μl. C-reactive protein was 5.3mg/dl. A bottle of blood culture was extracted and empirical antibiotic treatment with ampicillin (50mg/kg/dose every 12h) and tobramycin (5mg/kg/dose every 48h) was established.

The histological examination of the placenta revealed active sites of chorioamnionitis, and a Gram-negative bacillus was isolated from the microbiological culture after 48h of incubation. The colonies grown in blood agar presented a classic punctiform shape with grey, translucent, non-haemolytic circular borders (Fig. 1). They gave off a characteristic hypochlorite odour and were catalase-negative and oxidase-positive.

Fig. 1.

Appearance of the colonies in blood agar after 24h of incubation.


The bottle of blood culture was positive after 34h of incubation. After the Gram stain, which revealed Gram-negative coccobacilli, a subculture was prepared in chocolate agar and blood agar at 37°C and 5% CO2. After 24h of incubation, the colonies grown presented the same morphological and biochemical characteristics as the placenta culture. The automated Vitek 2® System (bioMérieux, Spain) was used to identify both microorganisms, but it failed to do so. Presumptive identification was performed using clinical chemistry tests (negative indole, positive ornithine decarboxylase and prolyl arylamidase, no carbohydrate fermentation). Finally, the 16S ribosomal RNA gene was amplified and sequenced, confirming both bacteria to be E. corrodens.

The sensitivity test was performed using antibiotic gradient strips in Müeller-Hinton agar, supplemented with 5% blood and NAD (MH-F, Oxoid). According to the CLSI M45 guidelines,2 the isolated strains were sensitive to penicillin (MIC: 1μg/ml), amoxicillin–clavulanic acid (MIC: 1μg/ml), cefotaxime (MIC: 0.06μg/ml), erythromycin (MIC: 4μg/ml), ciprofloxacin (MIC: 0.006μg/ml), cotrimoxazole (MIC: <0.002μg/ml) and doxycycline (MIC: 1μg/ml), intermediate to gentamicin (MIC: 4μg/ml) and amikacin (MIC: 16μg/ml), and resistant to clindamycin (MIC: >256μg/ml) and metronidazole (MIC: >256μg/ml), consistent with the antibiotic sensitivity described in the bibliography for this microorganism.1

The bacteria E. corrodens has traditionally been included in the so-called HACEK group of slow-growing, fastidious microorganisms, which are made up of the following genera: Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella and Kingella.

Penicillin G or amoxicillin-clavulanic acid are considered the treatment of choice. In our case, after obtaining the antibiogram, intravenous penicillin G was administered (50,000IU/kg/dose every 12h for 7 days), with favourable progression and sterile blood culture at 5 days of life.

Very few cases of neonatal sepsis caused by E. corrodens have been published.3–5 It is usually isolated in mixed infections, in patients with some degree of immunosuppression. In the case presented, E. corrodens chorioamnionitis was caused by genital colonisation of the bacteria during pregnancy, that ascended from the vagina. Some authors have suggested that oral sex during pregnancy may trigger chorioamnionitis by this microorganism.6–9 It is presumed that the neonatal sepsis was vertically transmitted.

Infections caused by E. corrodens may be underestimated because of the bacteria's slow growth and due to the fact that they may be present in mixed infections, thereby hindering their microbiological identification.

Conflicts of interest

The authors declare that they have no conflicts of interest.

P.R. Murray, E.J. Baron, J.H. Jorgensen, M.L. Landry, M.A. Pfaller.
Manual of clinical microbiology.
9th edition, ASM Press, (2007), pp. 621-635
Clinical and Laboratory Standards Institute: methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria.
3rd edition, Approved standard M45. CLSI, (2015),
M.T. Andrés, M.C. Martín, J.F. Fierro, F.J. Méndez.
Chorioamnionitis and neonatal septicaemia caused by Eikenella corrodens.
J Infect, 44 (2002), pp. 133-134
E. Cendejas Bueno, M.P. Romero Gómez, J.A. Sáez Nieto, F. Omeñaca Terés, S. Ares Segura, P. Peña García.
Sepsis neonatal por Eikenella corrodens.
An Pediatr (Barc), 67 (2007), pp. 603-614
F. Garnier, G. Masson, A. Bedu, P. Masson, E. Decroisette, V. Guigonis, et al.
Maternofetal infections due to Eikenella corrodens.
J Med Microbiol, 58 (2009), pp. 273-275
A.R. Jadhav, M.A. Belfort, G.A. Dildy.
Eikenella corrodens chorioamnionitis: modes of infection.
Am J Obstet Gyncol, 200 (2009), pp. 4-5
K.G. Jeppson, L.G. Reimer.
Eikenella corrodens chorioamnionitis.
Obstet Gynecol, 78 (1991), pp. S503-S505
J.M. Sporken, H.L. Muytjens, H.M. Vemer.
Intra-uterine infection due to Eikenella corrodens.
Acta Obstet Gynecol Scand, 64 (1985), pp. 683-684
S. Kostadinov, H. Pinar.
Amniotic fluid infection syndrome and neonatal mortality caused by Eikenella corrodens.
Pediatr Dev Pathol, 8 (2005), pp. 489-492

Please cite this article as: Angulo López I, Aguirre Quiñonero A, Fernández Torres M, Alegría Echauri E. Corioamnionitis y sepsis neonatal causada por Eikenella corrodens. Enferm Infecc Microbiol Clin. 2017;35:266–267.

Copyright © 2016. Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.